Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Bone & Joint Health Supplements Market

Bone & Joint Health Supplements Market Share

Report ID: GMI7684
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Bone & Joint Health Supplements Market Share

The bone & joint health supplements industry is characterized by a diverse array of players engaged in strategic initiatives to strengthen their market position and cater to the evolving needs of consumers.

Bone & Joint Health Supplements Market Companies

Prominent players operating in the bone & joint health supplements industry is as mentioned below:

Bayer AG
Amway
BASF SE
Vita Life Sciences Ltd
Glanbia plc
Arazo Nutrition
Reckitt Benckiser Group plc
Nature's Bounty, Inc.
NOW Foods
GNC Holdings, LLC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for bone & joint health supplements was valued at USD 13.6 billion in 2023 and is anticipated to observe over 7.5% CAGR from 2024 to 2032 attributed to the increasing ageing population and the rising prevalence of bone-related disorders.

The vitamins & minerals segment accounted for a significant market share of 50.1% in 2023 and will grow significantly through 2032 as they are easily accessible and affordable, making them more widely available to a diverse consumer base.

North America market size was USD 5.2 billion in 2023 and is expected to expand by 2032 with the growing geriatric population along with the higher prevalence of bone and joint health issues, such as osteoporosis and arthritis.

Bayer AG, Amway, BASF SE, Vita Life Sciences Ltd, Glanbia plc, Arazo Nutrition, Reckitt Benckiser Group plc, Nature's Bounty, Inc., NOW Foods, and GNC Holdings, LLC.